Cardiac Rehabilitation to Improve Breast Cancer Outcomes
- Conditions
- Cardiovascular DiseasesBreast Cancer
- Interventions
- Other: Cardiac Rehab
- Registration Number
- NCT05867667
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Brief Summary
To develop a novel, proactive cardiac rehabilitation program for breast cancer survivors at enhanced risk of cardiovascular disease. Considering this program is secondary to the Michigan Medicine Cardiac Rehabilitation program's goal to manage cardiac patients, the hybrid program has been designed that limits utilization of cardiac rehabilitation to 12 visits over the first eight weeks of the intervention compared to 32 visits for cardiovascular patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 4
- Breast cancer diagnosis stage I-III
- Within 18-months of treatment completion (defined as completion of all oncologic treatments expect oral maintenance therapy)
- Age 18 years or older
- At increased risk for cardiovascular disease based on one of the following; a.Treatment with either anthracycline-based or anti-HER2 therapy-based treatment regimen plus the presence of: >2 cardiovascular heart disease risk factors (smoking, hypertension, diabetes mellitus, obesity, dyslipidemia), OR Age (>60 years) at cancer treatment, OR Left ventricular ejection fraction <50%as determined with a clinically ordered echo scan within 6 months of enrollment, b.Treatment with anthracycline followed by trastuzumab
- Ability to understand and the willingness to sign a written informed consent.
- Planned surgery during the study period.
- Under cardiology care for known high-risk cardiovascular disease defined as the presence of any of the following: severe, unrevascularized coronary artery disease, severe valvular heart disease, advanced heart failure with a left ventricular ejection fraction <35%)
- Metastatic cancer
- Unable to exercise (e.g., inability to complete a modified stress test or musculoskeletal condition that prevents adequate participation in exercise)
- Adults unable to give consent, pregnant or lactating women, and prisoners are excluded from this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Cardiac Rehabilitation to Improve Breast Cancer Outcomes Cardiac Rehab 12 weeks of Cardiac Rehab
- Primary Outcome Measures
Name Time Method Change in cardiovascular fitness (as assessed using VO2max) between baseline and after 12 weeks of participation in a tapered 12-week cardiac rehabilitation program. up to 12 weeks after enrollment Change in cardiovascular fitness will be based on endpoints related to aerobic and anaerobic thresholds, including an increase in post maximal oxygen consumption (VO2max). VO2max will be assessed by indirect calorimetry (COSMED) during a graded exercise stress test using the Bruce protocol.
- Secondary Outcome Measures
Name Time Method changes in upper body strength between baseline and after a 12-week hybrid cardiac rehabilitation program. up to 12 weeks after enrollment Change in muscular strength will be assessed using 5-RM tests. The tests will be performed for leg extension, leg flexion, chest press, lat pull down, and bicep curl.
changes in lower body strength between baseline and after a 12-week hybrid cardiac rehabilitation program. up to 12 weeks after enrollment Change in muscular strength will be assessed using 5-RM tests. The tests will be performed for leg extension, leg flexion, chest press, lat pull down, and bicep curl.
Trial Locations
- Locations (1)
University of Michigan Rogel Cancer Center
🇺🇸Ann Arbor, Michigan, United States